Blue Water Vaccines Inc. Business Finance Contracts & Agreements
34 Contracts & Agreements
- Debenture Agreements (2 contracts)
- Exchange Agreements (1)
- Forbearance Agreements (2)
- Purchase Agreements (8)
- Registration Rights Agreements (3)
- Stock Agreements (4)
- Subscription Agreements (1)
- Underwriting Agreements (3)
- Warrant Agreements (10)
- ELOC Purchase Agreement dated October 2, 2024 (Filed With SEC on November 12, 2024)
- Form of ELOC Registration Rights Agreement dated October 2, 2024 (Filed With SEC on October 3, 2024)
- Form of ELOC Purchase Agreement dated October 2, 2024 (Filed With SEC on October 3, 2024)
- Form of Registration Rights Agreement dated as of October 2, 2024 relating to the resale of the shares of Common Stock underlying the Series C Preferred Stock and Warrants (Filed With SEC on October 3, 2024)
- Form of Securities Purchase Agreement dated October 2, 2024 relating to the sale of the Series C Preferred Stock and Warrants (Filed With SEC on October 3, 2024)
- Form of Warrant (Filed With SEC on October 3, 2024)
- Amended and Restated Forbearance Agreement between the Company and Veru, dated September 19, 2024 (Filed With SEC on September 20, 2024)
- Amendment to Non-Convertible Debenture, dated April 24, 2024, between the Company and Altos (Filed With SEC on April 26, 2024)
- Forbearance Agreement, dated April 24, 2024, between the Company and Veru (Filed With SEC on April 26, 2024)
- Debenture, dated January 23, 2024 (Filed With SEC on January 29, 2024)
- Form of Subscription Agreement, dated December 15, 2023, by and among Onconetix, Proteomedix, and the Investor (Filed With SEC on December 21, 2023)
- Certificate of Designation of Series B Convertible Preferred Stock (Filed With SEC on December 21, 2023)
- Share Exchange Agreement, dated December 15, 2023, by and among Onconetix, Proteomedix AG, Thomas Meier and the Sellers (Filed With SEC on December 21, 2023)
- Form of Amendment, dated October 5, 2023, to Asset Purchase Agreement, dated June 13, 2023, by and among WraSer, LLC, Xspire Pharma, LLC, Legacy-Xspire Holdings, LLC and Blue... (Filed With SEC on October 20, 2023)
- Amendment to Asset Purchase Agreement, dated as of September 29, 2023, by and between Blue Water Biotech, Inc. and Veru Inc (Filed With SEC on October 3, 2023)
- Asset Purchase Agreement, dated June 13, 2023, by and among WraSer, LLC, Xspire Pharma, LLC, Legacy-Xspire Holdings, LLC and Blue Water Biotech, Inc (Filed With SEC on June 14, 2023)
- Asset Purchase Agreement, dated as of April 19, 2023, between Veru Inc. and Blue Water Vaccines Inc (Filed With SEC on April 20, 2023)
- Form of Registration Rights Agreement, dated as of August 9, 2022, by and among the Company and the Purchasers (Filed With SEC on August 11, 2022)
- Form of Securities Purchase Agreement, dated as of August 9, 2022, by and among the Company and the Purchasers (Filed With SEC on August 11, 2022)
- Form of Pre-Funded Common Stock Purchase Warrant, by and among the Company and the holders (Filed With SEC on August 11, 2022)
- Form of Registration Rights Agreement, dated as of April 13, 2022, by and among the Company and the Purchasers (Filed With SEC on April 19, 2022)
- Form of Securities Purchase Agreement, dated as of April 13, 2022, by and among the Company and the Purchasers (Filed With SEC on April 19, 2022)
- Form of Pre-Funded Common Stock Purchase Warrant, by and among the Company and the holders (Filed With SEC on April 19, 2022)
- Representatives Warrant (Filed With SEC on February 24, 2022)
- Underwriting Agreement (Filed With SEC on February 24, 2022)
- Form of Representatives Warrant (Filed With SEC on February 8, 2022)
- Form of Underwriting Agreement (Filed With SEC on February 8, 2022)
- Form of Warrant Agency Agreement (Filed With SEC on January 6, 2022)
- Form of Warrant (Filed With SEC on January 6, 2022)
- Form of Warrant Agency Agreement (Filed With SEC on December 29, 2021)
- Form of Warrant (Filed With SEC on December 29, 2021)
- Form of Representatives Warrant (included in Exhibit 1.1) (Filed With SEC on December 29, 2021)
- Form of Underwriting Agreement (Filed With SEC on December 29, 2021)
- Specimen Common Stock Certificate (Filed With SEC on November 5, 2021)
